| DFUSX | VTSMX | DFUSX / VTSMX | |
| Total Expense Ratio | 0.08 | 0.14 | 57% |
| Annual Report Gross Expense Ratio | 0.10 | 0.14 | 71% |
| Fund Existence | 26 years | 34 years | - |
| Gain YTD | 17.094 | 15.489 | 110% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 13.6B | 2.05T | 1% |
| Annual Yield % from dividends | 1.07 | 1.02 | 105% |
| Returns for 1 year | 13.97 | 11.43 | 122% |
| Returns for 3 years | 61.53 | 64.40 | 96% |
| Returns for 5 years | 68.36 | 77.17 | 89% |
| Returns for 10 years | 188.28 | 223.01 | 84% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JMID | 29.48 | 0.10 | +0.35% |
| Janus Henderson Mid Cap Growth Alpha ETF | |||
| QDPL | 42.42 | 0.04 | +0.09% |
| Pacer Metaurus US Lg Cp Dvd Mltp 400 ETF | |||
| LLDR | 46.10 | N/A | N/A |
| Global X Long-Term Treasury Ladder ETF | |||
| INCO | 64.63 | -0.65 | -1.00% |
| Columbia India Consumer ETF | |||
| FMED | 28.08 | -0.29 | -1.02% |
| Fidelity Disruptive Medicine ETF | |||